The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

CORONARY INTERVENTIONS

Bivalirudin infusion to reduce ventricular infarction: the open-label, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) study

EuroIntervention 2017;13:e540-e548 published online ahead of print May 2017 published online e-edition August 2017. DOI: 10.4244/EIJ-D-17-00307

1. Erasmus MC, Rotterdam, the Netherlands; 2. Hôpital AP-HP Lariboisière, Paris, France; 3. Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; 4. Hôpital Ambroise Paré, Boulogne, France; 5. Hôpital Privé Jacques Cartier, Ramsay Générale de Santé, I

Aims: The aim of the study was to investigate whether bivalirudin versus unfractionated heparin (UFH) reduces infarct size (IS) for primary percutaneous coronary intervention (PPCI) in la

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Comparison of a new slender 6 Fr sheath with a standard 5 Fr sheath for transradial coronary angiography and intervention: RAP and BEAT (Radial Artery Patency and Bleeding, Efficacy, Adverse evenT), a randomised multicentre trial